3,553
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy

, , , , , & show all
Pages 209-223 | Received 30 Jul 2016, Accepted 03 Oct 2016, Published online: 03 Feb 2017

References

  • Aggarwal BB, Deb L, Prasad S. (2014). Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules 20:185–205
  • Alexis F, Pridgen EM, Langer R, Farokhzad OC. (2010). Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol 197:55–86
  • Anand P, Sundaram C, Jhurani S, et al. (2008). Curcumin and cancer: an old-age disease with an age-old solution. Cancer Lett 267:133–64
  • Andrade J, Hlady V, Jeon S. (1993). Polyethylene oxide and protein resistanceed. Washington (DC): ACS. 11p
  • Anuchapreeda S, Fukumori Y, Okonogi S, Ichikawa H. (2011). Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. J Nanotechnol 2012
  • Biswas S, Torchilin VP. (2014). Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev 66:26–41
  • Chen CJ, Wang JC, Zhao EY, et al. (2013). Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery. Biomaterials 34:5303–16
  • Cheng W, Kumar JN, Zhang Y, Liu Y. (2014). pH- and redox-responsive poly(ethylene glycol) and cholesterol-conjugated poly(amido amine)s based micelles for controlled drug delivery. Macromol Biosci 14:347–58
  • Dhillon N, Aggarwal BB, Newman RA, et al. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res 14:4491–9
  • Dutta P, Dey J. (2011). Drug solubilization by amino acid based polymeric nanoparticles: characterization and biocompatibility studies. Int J Pharm 421:353–63
  • Endres TK, Beck-Broichsitter M, Samsonova O, et al. (2011). Self-assembled biodegradable amphiphilic PEG–PCL–lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials 32:7721–31
  • Gref R, Lück M, Quellec P, et al. (2000). “Stealth” corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 18:301–13
  • Gref R, Minamitake Y, Peracchia MT, et al. (1994). Biodegradable long-circulating polymeric nanospheres. Science 263:1600–3
  • Griesser M, Pistis V, Suzuk T, et al. (2011). Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem 286:1114–24
  • Ha W, Wu H, Wang XL, et al. (2011). Self-aggregates of cholesterol-modified carboxymethyl konjac glucomannan conjugate: preparation, characterization, and preliminary assessment as a carrier of etoposide. Carbohydrate Polym 86:513–19
  • Hassaninasab A, Hashimoto Y, Tomita-Yokotan K, et al. (2011). Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci 108:6615–20
  • Hoehle SI, Pfeiffer E, Sólyom AM, et al. (2006). Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54:756–64
  • Jain AK, Goyal AK, Gupta PN, et al. (2009). Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release 136:161–9
  • Ireson C, Orr S, Jones DJ, et al. (2001). Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61:1058–64
  • Ireson CR, Jones DJ, Orr S, et al. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105–11
  • Kawamori T, Lubet R, Steele VE, et al. (1999). Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59:597–601
  • Kim TH, Jiang HH, Youn YS, et al. (2011). Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–91
  • Kumari P, Ghosh B, Biswas S. (2016a). Nanocarriers for cancer-targeted drug delivery. J Drug Target 24:179–91
  • Kumari P, Swami MO, Nadipalli SK, et al. (2016b). Curcumin delivery by poly (Lactide)-based co-polymeric micelles: an in vitro anticancer study. Pharm Res 33:826–41
  • Lee AL, Venkataraman S, Sirat SB, et al. (2012). The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs. Biomaterials 33:1921–8
  • Li Y, Kwon GS. (2000). Methotrexate esters of poly (ethylene oxide)-block-poly (2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 17:607–11
  • Liu L, Li C, Li X, et al. (2001). Biodegradable polylactide/poly (ethylene glycol)/polylactide triblock copolymer micelles as anticancer drug carriers. J Appl Polym Sci 80:1976–82
  • Ma Q, Li B, Yu Y, et al. (2013). Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier. Int J Pharm 445:88–92
  • Maxfield FR, Tabas I. (2005). Role of cholesterol and lipid organization in disease. Nature 438:612–21
  • Meng H, Xue M, Xia T, et al. (2011). Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano. 5:4131–44
  • Mittal G, Sahana D, Bhardwaj V, Kumar MR. (2007). Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119:77–85
  • Mock CD, Jordan BC, Selvam C. (2015). Recent advances of curcumin and its analogues in breast cancer prevention and treatment. RSC Adv 5:75575–88
  • Nagarwal RC, Kant S, Singh P, et al. (2009). Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 136:2–13
  • Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. (2014). Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 35:3365–83
  • Nishiyama N, Okazaki S, Cabral H, et al. (2003). Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63:8977–83
  • Owens DE, Peppas NA. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
  • Pan M-H, Huang T-M, Lin J-K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–94
  • Rao SB, Sharma CP. (1997). Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 34:21–8
  • Ruan G, Feng SS. (2003). Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037–44
  • Shaikh J, Ankola D, Beniwal V, et al. (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–30
  • Shuai X, Ai H, Nasongkla N, et al. (2004). Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 98:415–26
  • Song L, Shen Y, Hou J, et al. (2011). Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloids Surf A Physicochem Eng Asp 390:25–32
  • Srivastava RM, Singh S, Dubey SK, et al. (2011). Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol 11:331–41
  • Tan S, Rupasinghe TW, Tull DL, et al. (2014). Degradation of curcuminoids by in vitro pure culture fermentation. J Agric Food Chem 62:11005–15
  • Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
  • Varshosaz J, Ghaffari S, Khoshayand MR, et al. (2010). Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res 20:97–104
  • Wang DK, Varanasi S, Fredericks PM, et al. (2013). FT‐IR characterization and hydrolysis of PLA‐PEG‐PLA based copolyester hydrogels with short PLA segments and a cytocompatibility study. J Polym Sci A Polym Chem 51:5163–76
  • Wang H, Zhao P, Liang X, et al. (2010). Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 31:4129–38
  • Wang Y-J, Pan M-H, Cheng A-L, et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867–76
  • Wei Z, Hao J, Yuan S, et al. (2009). Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 376:176–85
  • Wichitnithad W, Nimmannit U, Callery PS, Rojsitthisak P. (2011). Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono‐PEGylated curcumin conjugates. J Pharm Sci 100:5206–18
  • Wu H, Zhu L, Torchilin VP. (2013). pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 34:1213–22
  • Wu J-C, Tsai M-L, Lai C-S, et al. (2014). Chemopreventative effects of tetrahydrocurcumin on human diseases. Food Funct 5:12–17
  • Wu X, Xu J, Huang X, Wen C. (2011). Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm 37:15–23
  • Xiao RZ, Zeng ZW, Zhou GL, et al. (2010). Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine 5:1057–65
  • Yao X, Chen L, Chen X, et al. (2014). Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery. Colloids Surf B 121:36–43
  • Yeagle PL. (1985). Cholesterol and the cell membrane. Biochim Biophys Acta 822:267–87
  • Yeagle PL. (1991). Modulation of membrane function by cholesterol. Biochimie 73:1303–10
  • Yokoyama M, Fukushima S, Uehara R, et al. (1998). Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 50:79–92
  • Zhang X, Li Y, Chen X, et al. (2005). Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. Biomaterials 26:2121–8
  • Zhou Y, Briand VA, Sharma N, et al. (2009). Polymers comprising cholesterol: synthesis, self-assembly, and applications. Materials 2:636–60